South African pharmacy chain Dis-Chem has deployed R240 million into replatforming its digital infrastructure and operational environment through its innovation division, X, Bigly Labs, established in late 2025.
Read: Apple unveils 2026 iMac with M6 and upgraded AI architecture
Details disclosed in the group’s interim results for the six months ending August 2026 highlight that the capital outlay went toward re-engineering Dis-Chem’s core e-commerce engine and enhancing retail execution.
Key digital milestones include:
- Pharmacy and Clinic Digitisation: The updated e-commerce architecture is serving as a blueprint for digitising Dis-Chem’s in-store pharmacy and clinic operations.
- Customer Application: The newly launched mobile app has reached 22,000 registered users, with a secondary rollout scheduled for the final quarter of the 2027 financial year to broaden consumer adoption.
- Data-Led Commercial Strategy: Insights generated by X, Bigly Labs will drive personalized promotional targeting, predictive analytics, and revenue-based store refurbishment prioritization.
Despite solid top-line revenue growth supported by customer engagement initiatives, Dis-Chem recorded lower bottom-line margins for the interim period due to front-loaded digital investments.
The updated Better Rewards loyalty scheme contributed significantly to top-line performance, accounting for 86.1% of total sales and returning R1.5 billion to members.
Management attributed the profit decline to a higher invested cost base in the second half of FY2026. Dis-Chem Group CEO Rui Morais noted that earnings are expected to balance out across the full financial year, supported by a stronger second-half performance.
